These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2139060)

  • 1. Does melancholia predict response in major depression?
    Nelson JC; Mazure CM; Jatlow PI
    J Affect Disord; 1990 Mar; 18(3):157-65. PubMed ID: 2139060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of desipramine-refractory depression.
    Nelson JC; Mazure CM; Jatlow PI
    J Clin Psychiatry; 1994 Jan; 55(1):12-9. PubMed ID: 8294386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of the DST for predicting response of patients with major depression to hospitalization and desipramine.
    Nelson JC; Mazure CM; Jatlow PI
    Am J Psychiatry; 1990 Nov; 147(11):1488-92. PubMed ID: 2221161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desipramine plasma concentration and antidepressant response.
    Nelson JC; Jatlow P; Quinlan DM; Bowers MB
    Arch Gen Psychiatry; 1982 Dec; 39(12):1419-22. PubMed ID: 7149903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-responsive symptoms in melancholia.
    Nelson JC; Mazure C; Quinlan DM; Jatlow PI
    Arch Gen Psychiatry; 1984 Jul; 41(7):663-8. PubMed ID: 6732425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response to desipramine treatment in adolescent major depression.
    Boulos C; Kutcher S; Marton P; Simeon J; Ferguson B; Roberts N
    Psychopharmacol Bull; 1991; 27(1):59-65. PubMed ID: 1862207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Desipramine plasma levels and response in elderly melancholic patients.
    Nelson JC; Jatlow PI; Mazure C
    J Clin Psychopharmacol; 1985 Aug; 5(4):217-20. PubMed ID: 4019810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of adinazolam and desipramine in the treatment of major depression.
    Kennedy SH; de Groot J; Ralevski E; Reed K
    Int Clin Psychopharmacol; 1991; 6(2):65-76. PubMed ID: 1960382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melancholic/endogenous depression and response to somatic treatment and placebo.
    Peselow ED; Sanfilipo MP; Difiglia C; Fieve RR
    Am J Psychiatry; 1992 Oct; 149(10):1324-34. PubMed ID: 1388334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic criteria for melancholia. The comparative validity of DSM-III and DSM-III-R.
    Zimmerman M; Black DW; Coryell W
    Arch Gen Psychiatry; 1989 Apr; 46(4):361-8. PubMed ID: 2930332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outpatients with DSM-III-R versus DSM-IV melancholic depression.
    Lafer B; Nierenberg AA; Rosenbaum JF; Fava M
    Compr Psychiatry; 1996; 37(1):37-9. PubMed ID: 8770524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidepressant pharmacotherapy and the treatment of depression in patients with severe traumatic brain injury: a controlled, prospective study.
    Wroblewski BA; Joseph AB; Cornblatt RR
    J Clin Psychiatry; 1996 Dec; 57(12):582-7. PubMed ID: 9010122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment outcome validation of DSM-III depressive subtypes. Clinical usefulness in outpatients with mild to moderate depression.
    Stewart JW; McGrath PJ; Liebowitz MR; Harrison W; Quitkin F; Rabkin JG
    Arch Gen Psychiatry; 1985 Dec; 42(12):1148-53. PubMed ID: 3907579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cluster analytic validation of the DSM melancholic depression. The threshold model: integration of quantitative and qualitative distinctions between unipolar depressive subtypes.
    Schotte CK; Maes M; Cluydts R; Cosyns P
    Psychiatry Res; 1997 Aug; 71(3):181-95. PubMed ID: 9271791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depression in children: relationship between plasma imipramine levels and response.
    Preskorn SH; Weller EB; Weller RA
    J Clin Psychiatry; 1982 Nov; 43(11):450-3. PubMed ID: 7174621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of hospital outcome without antidepressants in major depression.
    Mazure CM; Nelson JC; Jatlow PI
    Psychiatry Res; 1990 Jul; 33(1):51-8. PubMed ID: 2217658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of response to desipramine in dysthymia.
    Friedman RA; Parides M; Baff R; Moran M; Kocsis JH
    J Clin Psychopharmacol; 1995 Aug; 15(4):280-3. PubMed ID: 7593711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidepressant activity of 2-hydroxydesipramine.
    Nelson JC; Mazure C; Jatlow PI
    Clin Pharmacol Ther; 1988 Sep; 44(3):283-8. PubMed ID: 3416551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroleptic dose and desipramine concentrations during combined treatment of unipolar delusional depression.
    Nelson JC; Price LH; Jatlow PI
    Am J Psychiatry; 1986 Sep; 143(9):1151-4. PubMed ID: 3752299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melancholic Versus Non-Melancholic Depression: a Prospective Study.
    Munoli RN; Sharma PSVN; Kongasseri S; Bhandary RP; Praharaj SK
    East Asian Arch Psychiatry; 2020 Mar; 30(1):20-27. PubMed ID: 32229643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.